Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Peter Silverstone | M | - |
University of Alberta
| 32 years |
Laine M. Woollard | M | - |
University of Alberta
| 30 years |
Stephanie Gillis-Paulgaard | F | - |
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | 19 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Foster | M | 65 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | 20 years |
Launa J. Aspeslet | M | - |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.
University of Alberta
| 21 years |
Jonathan Goodman | M | 56 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | 1 years |
Franklin Berger | M | 74 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | 5 years |
Kevin Yakiwchuk | M | - |
University of Alberta
| 6 years |
Chad Robinson | M | - |
University of Alberta
| - |
Bryce Kremnica | M | - |
University of Alberta
| 5 years |
Ron Ritter | M | - |
University of Alberta
| 8 years |
Michael Brown | M | 52 |
University of Alberta
| 7 years |
Peter Wijngaard | M | 61 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | 2 years |
Mike H. Gilchrist | M | - |
University of Alberta
| 6 years |
Clemens Kaiser | M | - |
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada.
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | 2 years |
Christian Bayle | M | 55 |
University of Alberta
| 5 years |
Donald W. Wyatt | M | 57 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | 2 years |
Mary Ritchie | F | 67 |
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada.
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | 4 years |
Dennis Bourgeault | M | 66 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | 15 years |
Daniel Park | M | - |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | - |
Prakash Gowd | M | 60 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | 3 years |
Jeff Lawson | M | 55 |
University of Alberta
| 4 years |
Nancy Harrison | F | - |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | 1 years |
Colin R. Mallet | M | 80 |
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada.
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | - |
Stuart Olley | M | - |
University of Alberta
| 2 years |
Trina Richards | F | - |
University of Alberta
| 4 years |
Mohammad Tamim | M | 64 |
University of Alberta
| 3 years |
Mark Dmytruk | M | 52 |
University of Alberta
| 4 years |
Kris Smith | M | - |
University of Alberta
| 4 years |
Cameron R. Fink | M | 55 |
University of Alberta
| 4 years |
Mark G. Maybank | M | 53 |
University of Alberta
| 5 years |
Linnea Marie McKercher | F | - |
University of Alberta
| 4 years |
David Anderson | M | 54 |
University of Alberta
| 4 years |
Amir Arif | M | - |
University of Alberta
| 4 years |
Todd W. Cooper | M | 59 |
University of Alberta
| 4 years |
Jeffrey Johnson | M | - |
University of Alberta
| 4 years |
Paul Kristensen | M | - |
University of Alberta
| 4 years |
Richard W. Thomas | M | - |
University of Alberta
| 3 years |
James C. Lee | M | - |
University of Alberta
| 4 years |
John Bossio | M | 55 |
University of Alberta
| 4 years |
Jason Rosychuk | M | 50 |
University of Alberta
| 4 years |
Craig Senyk | M | - |
University of Alberta
| 4 years |
Keith J. Erickson | M | 51 |
University of Alberta
| 4 years |
Rajdeep Saran | M | - |
University of Alberta
| 4 years |
Simon Chen | M | 65 |
University of Alberta
| 3 years |
Banerjee Mila | F | - |
University of Alberta
| 4 years |
Congsin Congcar | M | 53 |
University of Alberta
| 3 years |
Craig Wilson | M | 52 |
University of Alberta
| 4 years |
Andrea Goertz | F | 53 |
University of Alberta
| 2 years |
David Kallay | M | 52 |
University of Alberta
| 4 years |
Conan Taylor | M | - |
University of Alberta
| 4 years |
Wai Yip Leung | M | 47 |
University of Alberta
| 4 years |
Gregory Bennett | M | 51 |
University of Alberta
| 4 years |
Darren Fast | M | - |
University of Alberta
| 3 years |
Richard Roy | M | - |
University of Alberta
| 4 years |
Garnet Olson | M | - |
University of Alberta
| 4 years |
Darren Hribar | M | - |
University of Alberta
| 3 years |
Ronald Kisic | M | - |
University of Alberta
| 3 years |
Michael Wasylynchuk | M | - |
University of Alberta
| 4 years |
Daniel McLeod | M | 54 |
University of Alberta
| 4 years |
Michael Sutton | M | - |
University of Alberta
| 5 years |
Raymond Schwartzenberger | M | - |
University of Alberta
| 4 years |
Shaun E. Alspach | M | - |
University of Alberta
| 4 years |
Darren Albert Dansereau | M | - |
University of Alberta
| 4 years |
Michael Tanton | M | - |
University of Alberta
| 4 years |
Allan Gregory Stepa | M | - |
University of Alberta
| 4 years |
Kelly D. Sledz | M | - |
University of Alberta
| 4 years |
Kevin Saskiw | M | - |
University of Alberta
| 4 years |
Jeffrey G. Sheremeta | M | 52 |
University of Alberta
| 4 years |
Miles W. Safranovich | M | - |
University of Alberta
| 4 years |
Daniel Ellis Kenney | M | - |
University of Alberta
| 3 years |
Kevin C. H. Lo | M | - |
University of Alberta
| 4 years |
Amit Monga | M | 56 |
University of Alberta
| 4 years |
Michael J. Rusch | M | 78 |
University of Alberta
| 4 years |
Douglas Bartole | M | 56 |
University of Alberta
| 4 years |
Norm A. Gretzinger | M | - |
University of Alberta
| 4 years |
Scott Reeves | M | 55 |
University of Alberta
| 3 years |
Patrice R. Debregeas | M | - |
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | - |
Shane Ebert | M | - |
University of Alberta
| 4 years |
Michael Allen | M | 49 |
University of Alberta
| 4 years |
Christopher R. Yellowega | M | 53 |
University of Alberta
| 4 years |
Kristopher Zack | M | - |
University of Alberta
| 4 years |
Katherine Bishop | M | 58 |
University of Alberta
| 3 years |
Joseph Brennan | M | 55 |
University of Alberta
| 3 years |
Dale Mah | M | - |
University of Alberta
| 4 years |
James Madro | M | - |
University of Alberta
| 4 years |
Ben Nyland | M | 54 |
University of Alberta
| 4 years |
Marc Belhumeur | M | - |
University of Alberta
| 4 years |
David Race | M | - |
University of Alberta
| 4 years |
Rachel Colabella | F | - |
University of Alberta
| 3 years |
Howard Dahl | M | 64 |
University of Alberta
| 4 years |
David Burton | M | - |
University of Alberta
| 4 years |
Troy G. Tews | M | - |
University of Alberta
| 4 years |
Brian D. Baker | M | - |
University of Alberta
| 4 years |
Kevin R. Mather | M | 51 |
University of Alberta
| 4 years |
Desmond Balakrishnan | M | 52 |
University of Alberta
| 3 years |
Tim D. Sweeney | M | - |
University of Alberta
| 4 years |
Dean Schultz | M | - |
University of Alberta
| 4 years |
Monroe Thomas | M | - |
University of Alberta
| 4 years |
Remco Adrianus Franciscus van Eeuwijk | M | 54 |
University of Alberta
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Derrick Freitag
- Personal Network